Bispecific Monoclonal Antibodies in Multiple Myeloma: Data from ASH 2022: A Podcast

<p>  </p> <p><strong>Article full text</strong></p> <p><br></p> <p> The above podcast audio represents the opinions of the <strong>authors</strong>. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online. (see “read the peer-reviewed publication” opposite). </p>